Kraj: Wielka Brytania
Język: angielski
Źródło: MHRA (Medicines & Healthcare Products Regulatory Agency)
Simvastatin
Milpharm Ltd
C10AA01
Simvastatin
10mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02120000; GTIN: 8901175038787
PACKAGE LEAFLET: INFORMATION FOR THE USER SIMVASTATIN 10 MG FILM-COATED TABLETS SIMVASTATIN 20 MG FILM-COATED TABLETS SIMVASTATIN 40 MG FILM-COATED TABLETS SIMVASTATIN 80 MG FILM-COATED TABLETS (Simvastatin) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Simvastatin is and what it is used for 2. What you need to know before you take Simvastatin 3. How to take Simvastatin 4. Possible side effects 5. How to store Simvastatin 6. Contents of the pack and other information 1. WHAT SIMVASTATIN IS AND WHAT IT IS USED FOR Simvastatin is a medicine used to lower levels of total cholesterol, “bad” cholesterol (LDL cholesterol) and fatty substances called triglycerides in the blood. In addition this medicine raises levels of “good” cholesterol (HDL cholesterol). This medicine is member of the class of drugs called statins. Cholesterol is one of several fatty substances found in the bloodstream. Your total cholesterol is made up mainly of LDL and HDL cholesterol. LDL cholesterol is often called “bad” cholesterol because it can build up in the walls of your arteries forming plaque. Eventually this plaque build-up can lead to a narrowing of the arteries. This narrowing can slow or block blood flow to vital organs such as the heart and brain. This blocking of blood flow can result in a heart attack or stroke. HDL cholesterol is often called “good” cholesterol because it helps keep the bad cholesterol from building up in the arteries and protects against heart disease. Triglycerides ar Przeczytaj cały dokument
OBJECT 1 Simvastatin 10mg Tablets Summary of Product Characteristics Updated 04-Feb-2022 | Aurobindo Pharma - Milpharm Ltd. • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Simvastatin 10 mg film-coated tablets 2. Qualitative and quantitative composition Each film-coated tablet contains 10 mg simvastatin. Excipient with known effect: Lactose monohydrate One film-coated tablet contains 70 mg lactose monohydrate. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Film-coated tablet. Light pink, round [diameter 6.1 mm] and biconvex film-coated tablets with “SI” debossed on one side and “10” on the other side. 4. Clinical particulars 4.1 Therapeutic indications Hypercholesterolaemia Treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments ( e.g exercise, weight reduction) is inadequate. Treatment of homozygous familial hypercholesterolaemia (HoFH) as a Przeczytaj cały dokument